Cardinal Health Inc (CAH) : Dividend Asset Capital scooped up 12,208 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 19, 2016. The investment management firm now holds a total of 1,541,817 shares of Cardinal Health Inc which is valued at $133,999,315.Cardinal Health Inc makes up approximately 3.73% of Dividend Asset Capital’s portfolio.
Cardinal Health Inc opened for trading at $86.9 and hit $87.3304 on the upside on Friday, eventually ending the session at $86.91, with a gain of 0.10% or 0.09 points. The heightened volatility saw the trading volume jump to 13,71,869 shares. Company has a market cap of $28,622 M.
Other Hedge Funds, Including , Rhenman Partners Asset Management Ab reduced its stake in CAH by selling 12,000 shares or 11.54% in the most recent quarter. The Hedge Fund company now holds 92,000 shares of CAH which is valued at $7,995,720. Cardinal Health Inc makes up approx 1.45% of Rhenman Partners Asset Management Ab’s portfolio.Sit Investment Associates Inc reduced its stake in CAH by selling 1,880 shares or 0.29% in the most recent quarter. The Hedge Fund company now holds 648,740 shares of CAH which is valued at $54,656,345. Cardinal Health Inc makes up approx 0.99% of Sit Investment Associates Inc’s portfolio.Denali Advisors boosted its stake in CAH in the latest quarter, The investment management firm added 3,900 additional shares and now holds a total of 37,800 shares of Cardinal Health Inc which is valued at $3,184,650. Cardinal Health Inc makes up approx 0.71% of Denali Advisors’s portfolio.British Columbia Investment Management Corp reduced its stake in CAH by selling 45,581 shares or 21.43% in the most recent quarter. The Hedge Fund company now holds 167,113 shares of CAH which is valued at $13,736,689. Cardinal Health Inc makes up approx 0.13% of British Columbia Investment Management Corp’s portfolio.
On the company’s financial health, Cardinal Health Inc reported $1.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Feb 1, 2016. Analyst had a consensus of $1.26. The company had revenue of $31445.00 million for the quarter, compared to analysts expectations of $29227.04 million. The company’s revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Avondale Initiated Cardinal Health Inc on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $111.Cardinal Health Inc was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016. Shares were Reiterated by RBC Capital Mkts on Feb 11, 2016 to “Outperform” and Lowered the Price Target to $ 95 from a previous price target of $105 .
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.